Research graph
References from Case Report: Erdheim-Chester disease presenting as abdominal cocoon syndrome. Local targets link to admitted publications; unresolved targets remain external evidence.
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
10.1182/blood.2019003507 · 2020 · External reference
Über lipoidgranulomatose
10.1007/bf01942684 · 1930 · External reference
Epidemiology of Erdheim-Chester disease in the United States: a SEER-based analysis
10.1016/j.bneo.2025.100188 · 2025 · External reference
Erdheim-chester disease
10.1182/blood.2019002766 · 2020 · External reference
Erdheim-Chester disease of the jaws: a case report and review of the literature
10.1007/s12105-025-01803-0 · 2025 · External reference
Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review
10.1097/01.md.0000145368.17934.91 · 2004 · External reference
Biliary manifestation of Erdheim–Chester disease mimicking Klatskin’s carcinoma
10.1111/j.1572-0241.2006.00893.x · 2007 · External reference
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
10.1182/blood-2014-03-561381 · 2014 · External reference
The clinical spectrum of Erdheim-Chester disease: an observational cohort study
10.1182/bloodadvances.2016001784 · 2017 · External reference
Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim‐Chester disease: Implications for pathogenesis
10.1002/art.22280 · 2006 · External reference
A patient with Erdheim-Chester disease presenting with intestinal obstruction as the initial symptom: a case report
10.3389/fonc.2022.849578 · 2022 · External reference
Age-related changes in circulating immune factors reveal biomarkers of immunosenescence
10.3389/fmed.2026.1729112 · 2026 · External reference
High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis
10.1182/blood-2017-01-761718 · 2017 · External reference
Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients
10.1182/blood-2010-10-313510 · 2011 · External reference
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationvemurafenib
10.1182/blood-2012-07-446286 · 2013 · External reference
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants
10.1038/s41375-025-02526-5 · 2025 · External reference
Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim‐Chester disease: Implications for pathogenesis
10.1002/art.22280 · ExternalCitation · doi-reference
Über lipoidgranulomatose
10.1007/bf01942684 · ExternalCitation · doi-reference
Erdheim-Chester disease of the jaws: a case report and review of the literature
10.1007/s12105-025-01803-0 · ExternalCitation · doi-reference
Epidemiology of Erdheim-Chester disease in the United States: a SEER-based analysis
10.1016/j.bneo.2025.100188 · ExternalCitation · doi-reference
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants
10.1038/s41375-025-02526-5 · ExternalCitation · doi-reference
Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review
10.1097/01.md.0000145368.17934.91 · ExternalCitation · doi-reference
Biliary manifestation of Erdheim–Chester disease mimicking Klatskin’s carcinoma
10.1111/j.1572-0241.2006.00893.x · ExternalCitation · doi-reference
Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients
10.1182/blood-2010-10-313510 · ExternalCitation · doi-reference
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationvemurafenib
10.1182/blood-2012-07-446286 · ExternalCitation · doi-reference
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
10.1182/blood-2014-03-561381 · ExternalCitation · doi-reference
High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis
10.1182/blood-2017-01-761718 · ExternalCitation · doi-reference
Erdheim-chester disease
10.1182/blood.2019002766 · ExternalCitation · doi-reference
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
10.1182/blood.2019003507 · ExternalCitation · doi-reference
The clinical spectrum of Erdheim-Chester disease: an observational cohort study
10.1182/bloodadvances.2016001784 · ExternalCitation · doi-reference
Age-related changes in circulating immune factors reveal biomarkers of immunosenescence
10.3389/fmed.2026.1729112 · ExternalCitation · doi-reference
A patient with Erdheim-Chester disease presenting with intestinal obstruction as the initial symptom: a case report
10.3389/fonc.2022.849578 · ExternalCitation · doi-reference
